Lauren B Arendse

Selective Inhibition of the C-Domain of ACE (Angiotensin-Converting Enzyme) Combined With Inhibition of NEP (Neprilysin)

R. Touyz, E. Sturrock, A. Harvey, 2021, Hypertension.

ANTIHYPERTENSIVE TREATMENT Selective Inhibition of the C-Domain of ACE (Angiotensin-Converting Enzyme) Combined With Inhibition of NEP (Neprilysin) A Potential New Therapy for Hypertension

R. Touyz, E. Sturrock, A. Harvey, 2021 .

Probing the Requirements for Dual Angiotensin-Converting Enzyme C-Domain Selective/Neprilysin Inhibition.

C. Eyermann, K. Chibale, G. Basarab, 2022, Journal of medicinal chemistry.

The anticancer human mTOR inhibitor sapanisertib potently inhibits multiple Plasmodium kinases and life cycle stages

E. Winzeler, G. Drewes, M. Bantscheff, 2022, Science Translational Medicine.

Novel Therapeutic Approaches Targeting the Renin-Angiotensin System and Associated Peptides in Hypertension and Heart Failure

R. Touyz, E. Sturrock, C. Llorens-Cortes, 2019, Pharmacological Reviews.

Plasmodium Kinases as Potential Drug Targets for Malaria: Challenges and Opportunities

I. Gilbert, K. Chibale, S. Wyllie, 2021, ACS infectious diseases.